Angiotensin converting enzyme (ACE) inhibitors are one of the most frequently used class of antihypertensive drugs in patients with hypertension, including those with RHTN (Jones et al., 2020; Unger et al., 2020). The gene discussed is ACE; the disease is hypertensive disorder.